New radiation method tested for prostate cancer in asia
NCT ID NCT02339701
First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study compares two radiation treatments for low or intermediate risk prostate cancer in Asian patients. One is a newer, shorter course called stereotactic body radiotherapy (SBRT), and the other is standard intensity-modulated radiotherapy (IMRT). The main goal is to see which one better preserves quality of life and has fewer side effects. About 68 participants will be followed for at least a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.